| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:30:03 UTC |
|---|
| Updated at | 2022-05-11 16:30:03 UTC |
|---|
| NP-MRD ID | NP0086754 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid |
|---|
| Description | (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid, also known as 15-keto-pge or 15-ketoprostaglandin e, belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. Prostaglandins are eicosanoids. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. The PGs and TXs are collectively identified as prostanoids (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. |
|---|
| Structure | CCCCCC(=O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,16-17,19,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t16-,17-,19-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate | ChEBI | | (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoate | Generator | | (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoic acid | Generator | | (13E)-11Α-hydroxy-9,15-dioxoprost-13-enoate | Generator | | (13E)-11Α-hydroxy-9,15-dioxoprost-13-enoic acid | Generator | | (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-en-1-Oic acid | HMDB | | (13E)-11a-Hydroxy-9,15-dioxoprost-13-en-1-Oate | HMDB | | (13E)-11a-Hydroxy-9,15-dioxoprost-13-en-1-Oic acid | HMDB | | (13E)-11alpha-Hydroxy-9,15-dioxoprost-13-en-1-Oate | HMDB | | (13E)-11Α-hydroxy-9,15-dioxoprost-13-en-1-Oate | HMDB | | (13E)-11Α-hydroxy-9,15-dioxoprost-13-en-1-Oic acid | HMDB | | (11a,13E)-11-Hydroxy-9,15-dioxoprost-13-en-1-Oate | HMDB | | (11a,13E)-11-Hydroxy-9,15-dioxoprost-13-en-1-Oic acid | HMDB | | (11alpha,13E)-11-Hydroxy-9,15-dioxoprost-13-en-1-Oate | HMDB | | (11alpha,13E)-11-Hydroxy-9,15-dioxoprost-13-en-1-Oic acid | HMDB | | (13E)-11-alpha-Hydroxy-9,15-dioxoprost-13-enoate | HMDB | | (13E)-11-alpha-Hydroxy-9,15-dioxoprost-13-enoic acid | HMDB | | 1-Hydroxy-9,15-dioxo-(11a,13E)-prost-13-en-1-Oate | HMDB | | 1-Hydroxy-9,15-dioxo-(11a,13E)-prost-13-en-1-Oic acid | HMDB | | 15-Keto pge1 | HMDB | | 15-Keto-pge | HMDB | | 15-Keto-pge1 | HMDB | | 15-Keto-pge1-alpha | HMDB | | 15-Keto-prostaglandin e1 | HMDB | | 15-Ketoprostaglandin e | HMDB | | 15-Ketoprostaglandin e1 | HMDB | | 15-oxo-PGE1 | HMDB | | 15-Oxoprostaglandin e1 | HMDB | | 3-Hydroxy-5-oxo-2-(3-oxo-1-octenyl)-cyclopentaneheptanoate | HMDB | | 3-Hydroxy-5-oxo-2-(3-oxo-1-octenyl)-cyclopentaneheptanoic acid | HMDB | | 9,15-Dioxo-11R-hydroxy-13E-prostaenoate | HMDB | | 9,15-Dioxo-11R-hydroxy-13E-prostaenoic acid | HMDB | | 15-Ketoprostaglandin e, (11alpha,13E)-(+-)-isomer | HMDB | | 15-Ketoprostaglandin e, (5Z,11alpha)-isomer, 2H-labeled | HMDB | | (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid | Generator |
|
|---|
| Chemical Formula | C20H32O5 |
|---|
| Average Mass | 352.4651 Da |
|---|
| Monoisotopic Mass | 352.22497 Da |
|---|
| IUPAC Name | 7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl]heptanoic acid |
|---|
| Traditional Name | 15-keto-PGE1 |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCC(=O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O |
|---|
| InChI Identifier | InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,16-17,19,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t16-,17-,19-/m1/s1 |
|---|
| InChI Key | VXPBDCBTMSKCKZ-XQHNHVHJSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Eicosanoids |
|---|
| Direct Parent | Prostaglandins and related compounds |
|---|
| Alternative Parents | |
|---|
| Substituents | - Prostaglandin skeleton
- Long-chain fatty acid
- Hydroxy fatty acid
- Cyclopentanol
- Acryloyl-group
- Cyclic alcohol
- Alpha,beta-unsaturated ketone
- Enone
- Cyclic ketone
- Secondary alcohol
- Ketone
- Carboxylic acid
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organooxygen compound
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|